Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 73, Issue 5, Pages S42-S46Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2015.07.049
Keywords
antiandrogens; antibacterials; evidence-based medicine; fumarates; hidradenitis suppurativa; immunosuppressants; retinoids; zinc
Categories
Funding
- AbbVie Corporation
Ask authors/readers for more resources
Traditional systemic therapies are frequently prescribed for the treatment of hidradenitis suppurativa (HS). Clinicians consider antibiotics, retinoids, antiandrogens, immunosuppressants, and less common treatment, such as fumarates, in the management of HS. Different classes of medications have been selected to treat HS based on their ability to target various pathways of the condition. Concerns about infection, such as infection with Clostridium difficile, necessitates switching therapy or shortening the course of therapy with specific antibiotics. This review explores the outcomes with the use of numerous medical therapies and postulates explanations for their efficacy or lack of response. Data on long-term safety and efficacy with traditional systemic therapies are lacking.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available